MANNKIND CORP (22)
- Business Finance (14)
- Business Operations (4)
- Human Resources (2)
- Uncategorized (2)
- Amendment No. 10 to the Credit and Security Agreement, dated August 29, 2022, by and among MannKind Corporation, MannKind LLC, QrumPharma, Inc., and MidCap Financial Trust (Filed With SEC on November 8, 2022)
- First Amendment to Commercial Supply Agreement, dated October 16, 2021, by and between MannKind Corporation and United Therapeutics Corporation (Filed With SEC on November 9, 2021)
- Offer Letter, dated August 11, 2003, by and between MannKind and Joseph Kocinsky (Filed With SEC on February 25, 2021)
- MannKind Corporation 2018 Equity Incentive Plan, as amended (Filed With SEC on August 5, 2020)
- Purchase and Sale Agreement, dated September 23, 2021, by and between MannKind Corporation and 1 Casper, LLC (Filed With SEC on November 9, 2021)
- Commercial Supply Agreement, dated August 12, 2021, by and between MannKind Corporation and United Therapeutics Corporation (Filed With SEC on November 9, 2021)
- Indenture, dated as of March 4, 2021, by and between MannKind Corporation and U.S. Bank National Association, as Trustee (Filed With SEC on March 5, 2021)
- Supply Agreement, dated as of July 31, 2014, by and between MannKind and Amphastar France Pharmaceuticals S.A.S (Filed With SEC on February 25, 2021)
- Offer Letter, dated May 7, 2020 by and between MannKind and Alejandro Galindo (Filed With SEC on February 25, 2021)
- Description of Common Stock (Filed With SEC on February 25, 2021)
- Amendment No. 4 to Credit and Security Agreement, dated December 7, 2020 by and among the Company, MannKind LLC and MidCap Financial Trust (Filed With SEC on December 7, 2020)
- Purchase Agreement, dated December 7, 2020 by and among the Company, the Acquired Company, the Sellers and the Securityholders Representative (Filed With SEC on December 7, 2020)
- Description of Common Stock (Filed With SEC on February 25, 2020)
- Amendment to Common Stock Purchase Warrant, dated December 22, 2019, by and between MannKind Corporation and CVI Investments, Inc (Filed With SEC on December 23, 2019)
- Form of 5.75% Convertible Senior Subordinated Exchange Notes Due 2024 (included in Exhibit 4.3 as Exhibit A thereto) (Filed With SEC on August 7, 2019)
- Promissory Note made by MannKind Corporation in favor of The Mann Group LLC, dated August 6, 2019 (Filed With SEC on August 7, 2019)
- Convertible Promissory Note made by MannKind Corporation in favor of The Mann Group LLC, dated August 6, 2019 (Filed With SEC on August 7, 2019)
- Promissory Note due December 31, 2020 made by MannKind Corporation in favor of Bruce & Co., Inc., dated August 6, 2019 (Filed With SEC on August 7, 2019)
- Promissory Note due June 30, 2020 made by MannKind Corporation in favor of Bruce & Co., Inc., dated August 6, 2019 (Filed With SEC on August 7, 2019)
- Form of Warrant to Purchase Stock (Filed With SEC on August 7, 2019)
- Fourth Amendment to Supply Agreement, dated December 24, 2018, by and between MannKind and Amphastar Pharmaceuticals, Inc (Filed With SEC on February 26, 2019)
- Non-Employee Director Compensation Program (Filed With SEC on February 26, 2019)
